ArticleBMJ open2024

Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial.

Feng Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.